Blood Advances Talks
Activity Overview
Episode publication activity over the past year
Episodes
GRNDaD: big data and sickle cell disease
09 Feb 2022
Contributed by Lukas
Big data are used in the pursuit of precision medicine in the general population. Applying these tools to patients with sickle cell disease (SCD) is e...
Investigational curative gene therapy approaches to sickle cell disease
26 Jan 2022
Contributed by Lukas
Sickle cell disease (SCD) is an inherited blood condition resulting from abnormal hemoglobin production. It is one of the most common genetic diseases...
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
26 Jan 2022
Contributed by Lukas
The prospect of a clinical strategy using an adeno-associated virus (AAV) vector for expression of therapeutic levels of factor VIII (FVIII) has been ...
Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding
01 Oct 2021
Contributed by Lukas
The availability of novel nonfactor therapeutics is revolutionizing the management of hemophilia in individuals with inhibitory antibodies, as well as...
Concizumab: a novel anti-TFPI therapeutic for hemophilia
12 Jan 2021
Contributed by Lukas
Amy Shapiro discusses the recent approval of concizumab for the treatment of patients with hemophilia. This novel subcutaneous homeostatic rebalancing...
Naive T-cell depletion in stem cell transplantation
13 Oct 2020
Contributed by Lukas
Allogeneic hematopoietic stem cell transplantation (HCT) is curative in many patients with advanced hematopoietic malignancies. Donor T cells not only...
The management of venous thromboembolism in hospitalized patients with COVID-19
15 Sep 2020
Contributed by Lukas
The high incidence of thromboembolic disease, and in particular venous thromboembolism (VTE), has emerged as an important consideration in hospitalize...
Gene therapy for hemophilia: anticipating the unexpected
15 Sep 2020
Contributed by Lukas
The treatment of hemophilia, which has undergone many transformative changes over the past 60 years, is poised for yet another disruptive change: the ...
The changing landscape of anticoagulation in cancer-associated thrombosis
10 Mar 2020
Contributed by Lukas
The changing landscape of anticoagulation in cancer-associated thrombosisÂ
TA-TMA: state of the art for diagnosis and treatment
14 Jan 2020
Contributed by Lukas
TA-TMA: state of the art for diagnosis and treatment by Blood Advances Talks
Inherited predisposition to myeloid malignancies
10 Sep 2019
Contributed by Lukas
Inherited predisposition to myeloid malignancies by Blood Advances Talks
Managing patients who are receiving warfarin (or DOAC)and need an elective surgery or procedure
25 Jun 2019
Contributed by Lukas
Managing patients who are receiving warfarin (or DOAC)and need an elective surgery or procedure by Blood Advances Talks
Daily light-and-darkness onset regulates mouse hematopoietic stem cells
26 Feb 2019
Contributed by Lukas
Daily light-and-darkness onset regulates mouse hematopoietic stem cells by Blood Advances Talks
Extended therapy for unprovoked venous thromboembolism: when is it indicated?
12 Feb 2019
Contributed by Lukas
Extended therapy for unprovoked venous thromboembolism: when is it indicated? by Blood Advances Talks
Antiplatelet therapy in the management of atherothrombosis: recent clinical advances
27 Jul 2018
Contributed by Lukas
Antiplatelet therapy in the management of atherothrombosis: recent clinical advances by Blood Advances Talks
Challenges facing the benign hematology physician-scientist workforce
13 Feb 2018
Contributed by Lukas
Challenges facing the benign hematology physician-scientist workforce by Blood Advances Talks
Choosing for whom to recommend allogeneic transplantation for AML in CRL
23 Jan 2018
Contributed by Lukas
Choosing for whom to recommend allogeneic transplantation for AML in CRL by Blood Advances Talks
Catalyzing innovation in clinical trial design and analysis at NHLBI
11 Jan 2018
Contributed by Lukas
Catalyzing innovation in clinical trial design and analysis at NHLBI by Blood Advances Talks
ITP and thrombosis: an intriguing association
16 Nov 2017
Contributed by Lukas
ITP and thrombosis: an intriguing association by Blood Advances Talks
The current therapeutic landscape of FLT3 inhibitors
16 Nov 2017
Contributed by Lukas
The current therapeutic landscape of FLT3 inhibitors by Blood Advances Talks
How many mice? Design considerations for murine studies
15 Aug 2017
Contributed by Lukas
How many mice? Design considerations for murine studies by Blood Advances Talks
The Direct Oral Anticoagulants – can we finally stop using rat poison?
19 Jun 2017
Contributed by Lukas
The Direct Oral Anticoagulants – can we finally stop using rat poison? by Blood Advances Talks
Impact of the ICAL on the treatment of acute leukemia
15 Mar 2017
Contributed by Lukas
Impact of the ICAL on the treatment of acute leukemia by Blood Advances Talks
Venetoclax: a primer
28 Feb 2017
Contributed by Lukas
Venetoclax: a primer by Blood Advances Talks
Technological Solutions For Global Hematology And Oncology
22 Feb 2017
Contributed by Lukas
Technological Solutions For Global Hematology And Oncology by Blood Advances Talks
The Lucky Iron Fish: a simple solution for iron deficiency
24 Jan 2017
Contributed by Lukas
The Lucky Iron Fish: a simple solution for iron deficiency by Blood Advances Talks
New developments in the management of sickle cell disease
01 Dec 2016
Contributed by Lukas
New developments in the management of sickle cell disease by Blood Advances Talks
Should we avoid heparin to eliminate HIT?
01 Dec 2016
Contributed by Lukas
Should we avoid heparin to eliminate HIT? by Blood Advances Talks